Australasian Diabetes Congress 2025

The Program Organising Committee (POC) invites submissions of papers of original contributions on any topic related to the following categories.

GROUP 1: Genetics/Epigenetics/Epidemiology

01 Epidemiology

02 Genetics of type 1 diabetes

03 Genetics of type 2 diabetes

04 Monogenic forms of diabetes

05 Environmental factors (viruses, nutrients, toxins)

06 Diabetes epigenetics

07 Prediction and prevention of type 1 diabetes

08 Prediction of type 2 diabetes

09 Prevention of type 2 diabetes

10 Risk of diabetes in immigrant populations

GROUP 2: Islets/Transplantation/Immunology type 1 diabetes

11 Developmental biology, pancreas

12 Stem cells and beta cell generation

13 Transcriptional regulation and protein synthesis, pancreas

14 Insulin secretion in vitro and exocytosis

15 Beta cell signal transduction

16 Beta cell damage, degeneration and apoptosis

17 Experimental immunology and animal models of type 1 diabetes

18 Clinical immunology

19 Inflammatory mediators in the pathogenesis of type 1 diabetes

20 Pancreas and islet transplantation

GROUP 3: Pathophysiology/Metabolism I

21 Insulin action

22 Insulin sensitivity and resistance

23 Insulin secretion in vivo

24 Gastro-entero pancreatic factors

25 Other hormones

26 Glucose transport

27 Carbohydrate metabolism

28 Protein metabolism

29 Exercise physiology

GROUP 4: Pathophysiology/Metabolism II

30 Inflammation in type 2 diabetes

31 Animal models of type 2 diabetes

32 Lipid metabolism

33 Adipose tissue biology and adipocytokines

34 Inflammation in obesity

35 Animal models of obesity

36 Weight regulation and obesity

37 Brain metabolism

GROUP 5: Clinical Science and Care I

38 Insulin

39 Integrated diabetes care

40 Transition (paediatric to adult care)

41 Inpatient diabetes

42 Nutrition and diet

43 Oral therapies: secretagogues

44 Oral therapies: metformin, sensitizers and other non-secretagogues

45 SGLT inhibitors

46 Incretin based therapies

47 Novel agents

GROUP 6: Clinical Science and Care II

48 Insulin therapy

49 Devices

50 Hypoglycaemia

51 Health care delivery

52 Education

53 Psychological aspects

54 Socio-economic aspects

GROUP 7: Complications I

55 Pregnancy

56 Neuropathy: somatic

57 Neuropathy: autonomic, incl. erectile dysfunction

58 Diabetic foot and skin disorders

59 Retinopathy

60 Nephropathy

61 Hypertension

GROUP 8: Complications II

62 Cardiac complications

63 Macrovascular disease

64 Pathogenic mechanisms / complications

65 Dyslipidaemia, lipoproteins

66 Endothelium

67 Animal models with complications

68 Other complications

69 Diabetes in childhood

70 Cancer

71 Cognitive dysfunction and Alzheimer Disease

72 Metabolic associated fatty liver disease (MAFLD)

73 Diabetes anxiety/distress